Intuitive Surgical (ISRG) Stock Forecast & Price Target

Compare

8,828 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ISRG Analyst Ratings

Strong Buy

16 Buy

4 Hold

0 Sell

Based on 20 analysts giving stock ratings to

Intuitive

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ISRG Stock 12 Month Forecast

Average Price Target

$637.32

▲(19.13% Upside)

Based on 20 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $637.32 with a high forecast of $740.00 and a low forecast of $575.00. The average price target represents a 19.13% change from the last price of $535.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"437":"$437","513":"$513","589":"$589","665":"$665","741":"$741"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":740,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$740.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":637.32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$637.32</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":575,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$575.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[437,513,589,665,741],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,566.36,579.7169230769231,593.0738461538461,606.4307692307692,619.7876923076923,633.1446153846153,646.5015384615385,659.8584615384616,673.2153846153847,686.5723076923077,699.9292307692308,713.2861538461539,726.6430769230769,{"y":740,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,566.36,571.8184615384615,577.2769230769231,582.7353846153846,588.1938461538462,593.6523076923078,599.1107692307693,604.5692307692308,610.0276923076923,615.4861538461539,620.9446153846154,626.4030769230769,631.8615384615385,{"y":637.32,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,566.36,567.0246153846153,567.6892307692308,568.3538461538461,569.0184615384616,569.6830769230769,570.3476923076923,571.0123076923077,571.6769230769231,572.3415384615384,573.0061538461539,573.6707692307692,574.3353846153847,{"y":575,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":521.96,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":571.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":573.15,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":496.36,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":517.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":553.29,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":537.99,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":483.12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":469.07,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":438.04,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":534.28,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":567.37,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":566.36,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$740.00

Average Price Target$637.32

Lowest Price Target$575.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Brandon Vazquez

William Blair

Buy

―

Reiterated

01/14/26

Intuitive Surgical: DV5 Adoption, Innovation Pipeline, and Robust Growth Outlook Support Premium-Valued Buy Rating

Shagun Singh Chadha

RBC Capital

$650

Buy

21.50%

Upside

Reiterated

01/14/26

RBC Capital Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Lee Hambright

Bernstein

$740

Buy

38.32%

Upside

Reiterated

01/13/26

Bernstein Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

David Roman

Goldman Sachs

$621→$714

Buy

33.46%

Upside

Reiterated

01/09/26

Intuitive Surgical price target raised to $714 from $621 at Goldman SachsIntuitive Surgical price target raised to $714 from $621 at Goldman Sachs

Matt Miksic

Barclays

$635→$686

Buy

28.22%

Upside

Reiterated

01/07/26

Barclays Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Ryan Zimmerman

BTIG

$589→$616

Buy

15.14%

Upside

Reiterated

01/07/26

Intuitive Surgical price target raised to $616 from $589 at BTIGIntuitive Surgical price target raised to $616 from $589 at BTIG

Vijay Kumar

Evercore ISI

$540→$580

Hold

8.41%

Upside

Reiterated

01/05/26

Intuitive Surgical price target raised to $580 from $540 at Evercore ISIIntuitive Surgical price target raised to $580 from $540 at Evercore ISI

Richard Newitter

Truist Financial

$620→$650

Buy

21.50%

Upside

Reiterated

12/18/25

Intuitive Surgical price target raised to $650 from $620 at TruistIntuitive Surgical price target raised to $650 from $620 at Truist

David Rescott

Robert W. Baird

$655

Buy

22.43%

Upside

Reiterated

12/16/25

Robert W. Baird Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)

Larry Biegelsen

Wells Fargo

$654→$600

Buy

12.15%

Upside

Reiterated

12/12/25

Wells Fargo Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Joanne Wuensch

Citi

$650→$635

Hold

18.69%

Upside

Downgraded

12/11/25

Citi downgrades Intuitive Surgical (ISRG) to a Hold

Travis Steed

Bank of America Securities

$650

Buy

21.50%

Upside

Reiterated

12/03/25

Intuitive Surgical: Buy Rating Backed by Innovative Imaging Technologies and Growth Potential

Danielle Antalffy

UBS

$585→$600

Hold

12.15%

Upside

Reiterated

10/23/25

UBS Reaffirms Their Hold Rating on Intuitive Surgical (ISRG)

Adam Maeder

Piper Sandler

$595→$610

Buy

14.02%

Upside

Reiterated

10/22/25

Piper Sandler Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

Jayson Bedford

Raymond James

$592→$603

Buy

12.71%

Upside

Reiterated

10/22/25

Intuitive Surgical price target raised to $603 from $592 at Raymond JamesIntuitive Surgical price target raised to $603 from $592 at Raymond James

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Brandon Vazquez

William Blair

Buy

―

Reiterated

01/14/26

Intuitive Surgical: DV5 Adoption, Innovation Pipeline, and Robust Growth Outlook Support Premium-Valued Buy Rating

Shagun Singh Chadha

RBC Capital

$650

Buy

21.50%

Upside

Reiterated

01/14/26

RBC Capital Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Lee Hambright

Bernstein

$740

Buy

38.32%

Upside

Reiterated

01/13/26

Bernstein Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

David Roman

Goldman Sachs

$621→$714

Buy

33.46%

Upside

Reiterated

01/09/26

Intuitive Surgical price target raised to $714 from $621 at Goldman SachsIntuitive Surgical price target raised to $714 from $621 at Goldman Sachs

Matt Miksic

Barclays

$635→$686

Buy

28.22%

Upside

Reiterated

01/07/26

Barclays Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Ryan Zimmerman

BTIG

$589→$616

Buy

15.14%

Upside

Reiterated

01/07/26

Intuitive Surgical price target raised to $616 from $589 at BTIGIntuitive Surgical price target raised to $616 from $589 at BTIG

Vijay Kumar

Evercore ISI

$540→$580

Hold

8.41%

Upside

Reiterated

01/05/26

Intuitive Surgical price target raised to $580 from $540 at Evercore ISIIntuitive Surgical price target raised to $580 from $540 at Evercore ISI

Richard Newitter

Truist Financial

$620→$650

Buy

21.50%

Upside

Reiterated

12/18/25

Intuitive Surgical price target raised to $650 from $620 at TruistIntuitive Surgical price target raised to $650 from $620 at Truist

David Rescott

Robert W. Baird

$655

Buy

22.43%

Upside

Reiterated

12/16/25

Robert W. Baird Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)

Larry Biegelsen

Wells Fargo

$654→$600

Buy

12.15%

Upside

Reiterated

12/12/25

Wells Fargo Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Joanne Wuensch

Citi

$650→$635

Hold

18.69%

Upside

Downgraded

12/11/25

Citi downgrades Intuitive Surgical (ISRG) to a Hold

Travis Steed

Bank of America Securities

$650

Buy

21.50%

Upside

Reiterated

12/03/25

Intuitive Surgical: Buy Rating Backed by Innovative Imaging Technologies and Growth Potential

Danielle Antalffy

UBS

$585→$600

Hold

12.15%

Upside

Reiterated

10/23/25

UBS Reaffirms Their Hold Rating on Intuitive Surgical (ISRG)

Adam Maeder

Piper Sandler

$595→$610

Buy

14.02%

Upside

Reiterated

10/22/25

Piper Sandler Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

Jayson Bedford

Raymond James

$592→$603

Buy

12.71%

Upside

Reiterated

10/22/25

Intuitive Surgical price target raised to $603 from $592 at Raymond JamesIntuitive Surgical price target raised to $603 from $592 at Raymond James

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

3 Months

xxx

Success Rate

23/29 ratings generated profit

Average Return

+8.36%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 79.31% of your transactions generating a profit, with an average return of +8.36% per trade.

1 Year

Lee HambrightBernstein

Success Rate

17/18 ratings generated profit

Average Return

+24.17%

reiterated a buy rating 6 days ago

Copying Lee Hambright's trades and holding each position for 1 Year would result in 94.44% of your transactions generating a profit, with an average return of +24.17% per trade.

2 Years

xxx

Success Rate

32/33 ratings generated profit

Average Return

+59.94%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 96.97% of your transactions generating a profit, with an average return of +59.94% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ISRG Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ISRG has received 18 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. ISRG average Analyst price target in the past 3 months is 637.32.

Each month's total comprises the sum of three months' worth of ratings.

ISRG Financial Forecast

ISRG Earnings Forecast

Next quarter’s earnings estimate for ISRG is $2.25 with a range of $2.12 to $2.42. The previous quarter’s EPS was $2.40. ISRG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year ISRG has Performed in-line its overall industry.

ISRG Sales Forecast

Next quarter’s sales forecast for ISRG is $2.74B with a range of $2.65B to $2.87B. The previous quarter’s sales results were $2.51B. ISRG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year ISRG has Performed in-line its overall industry.

ISRG Stock Forecast FAQ

What is ISRG’s average 12-month price target, according to analysts?

Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 637.32.

What is ISRG’s upside potential, based on the analysts’ average price target?

Intuitive Surgical has 19.13% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ISRG a Buy, Sell or Hold?

Intuitive Surgical has a consensus rating of Strong Buy which is based on 16 buy ratings, 4 hold ratings and 0 sell ratings.

What is Intuitive Surgical’s price target?

The average price target for Intuitive Surgical is 637.32. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $740.00 ,the lowest forecast is $575.00. The average price target represents 19.13% Increase from the current price of $535.

What do analysts say about Intuitive Surgical?

Intuitive Surgical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.

How can I buy shares of ISRG?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Intuitive Surgical (ISRG) Stock Forecast & Price Target

ISRG Analyst Ratings

ISRG Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Intuitive Surgical

ISRG Analyst Recommendation Trends

ISRG Financial Forecast

ISRG Earnings Forecast

ISRG Sales Forecast

ISRG Stock Forecast FAQ

Detailed List of Analyst Forecasts